These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6469132)

  • 21. The developmental toxicity of orally administered theophylline in rats and mice.
    Lindström P; Morrissey RE; George JD; Price CJ; Marr MC; Kimmel CA; Schwetz BA
    Fundam Appl Toxicol; 1990 Jan; 14(1):167-78. PubMed ID: 2155147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of heart malformations in B6C3F1 mouse fetuses induced by in utero exposure to methyl chloride.
    Wolkowski-Tyl R; Lawton AD; Phelps M; Hamm TE
    Teratology; 1983 Apr; 27(2):197-206. PubMed ID: 6867941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of maternal toxicity in lovastatin-induced developmental toxicity.
    Lankas GR; Cukierski MA; Wise LD
    Birth Defects Res B Dev Reprod Toxicol; 2004 Jun; 71(3):111-23. PubMed ID: 15282732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malformations in rat fetuses induced by trypan blue.
    Ema M; Itami T; Kawasaki H; Kanoh S
    Jikken Dobutsu; 1987 Jul; 36(3):261-5. PubMed ID: 3678370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Embryotoxicity and fetotoxicity following intraperitoneal administrations of hexavalent chromium to pregnant rats.
    Marouani N; Tebourbi O; Mokni M; Yacoubi MT; Sakly M; Benkhalifa M; Ben Rhouma K
    Zygote; 2011 Aug; 19(3):229-35. PubMed ID: 21205386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative effects of single intraperitoneal or oral doses of sodium arsenate or arsenic trioxide during in utero development.
    Stump DG; Holson JF; Fleeman TL; Nemec MD; Farr CH
    Teratology; 1999 Nov; 60(5):283-91. PubMed ID: 10525206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonists.
    Crofts F; Rohatagi S; Pino M; DeLise B; Zhang J; Nguyen M; Guittin P; Barbellion S; Brunel P; Hofmann T; Schmidt J; Wong M; Lockey P; Lerman S; Clark R
    Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):69-79. PubMed ID: 15098200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct fetal injections of diethylstilbestrol and 17 beta-estradiol: a method for investigating their teratogenicity.
    Henry EC; Miller RK; Baggs RB
    Teratology; 1984 Apr; 29(2):297-304. PubMed ID: 6740514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The area under the concentration-time curve of all-trans-retinoic acid is the most suitable pharmacokinetic correlate to the embryotoxicity of this retinoid in the rat.
    Tzimas G; Thiel R; Chahoud I; Nau H
    Toxicol Appl Pharmacol; 1997 Apr; 143(2):436-44. PubMed ID: 9144460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malformations caused in mouse embryos by a red dye contained in commmerical trypan blue.
    Bertini F; Sacerdote F
    Teratology; 1970 Nov; 3(4):371-6. PubMed ID: 5538416
    [No Abstract]   [Full Text] [Related]  

  • 31. Valproic acid in pregnancy: how much are we endangering the embryo and fetus?
    Ornoy A
    Reprod Toxicol; 2009 Jul; 28(1):1-10. PubMed ID: 19490988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Teratogenicity and embryolethality of acrolein and structurally related compounds in rats.
    Slott VL; Hales BF
    Teratology; 1985 Aug; 32(1):65-72. PubMed ID: 4035593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Teratogenicity and transplacental pharmacokinetics of 13-cis-retinoic acid in rabbits.
    Eckhoff C; Chari S; Kromka M; Staudner H; Juhasz L; Rudiger H; Agnish N
    Toxicol Appl Pharmacol; 1994 Mar; 125(1):34-41. PubMed ID: 8128493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Teratogenic effects of sodium valproate in mice and rats at midgestation and at term.
    Menegola E; Broccia ML; Nau H; Prati M; Ricolfi R; Giavini E
    Teratog Carcinog Mutagen; 1996; 16(2):97-108. PubMed ID: 8875740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of adult skeletons to detect prenatal exposure to trypan blue in mice.
    Beck SL
    Teratology; 1983 Oct; 28(2):271-85. PubMed ID: 6648830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of maternal exposure to toluene during pregnancy on mouse embryos and fetuses.
    Shigeta S; Aikawa H; Misawa T
    Tokai J Exp Clin Med; 1982 Mar; 7(2):265-70. PubMed ID: 7101330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electrocardiographic studies of developing rodents exposed in utero to trypan blue.
    Watkinson WP; Hoke EH; Whitehouse DA; Rogers EH; Robinson KS
    Prog Clin Biol Res; 1983; 140():207-22. PubMed ID: 6672837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Teratogenicity study of 2,2,3,3,3-pentafluoro-1-propanol (5FP) in rats by oral administration].
    Usami M; Sakemi K; Kurebayashi H; Ohno Y
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2000; (118):45-9. PubMed ID: 11534126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Developmental toxicity of 1,6-hexamethylene diisocyanate (HDI) in the Sprague-Dawley rat.
    Astroff AB; Sturdivant DW; Lake SG; Shiotsuka RN; Simon GS; Andrews LS
    Teratology; 2000 Oct; 62(4):205-13. PubMed ID: 10992262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gestational age dependency in the prenatal toxicity and in the disposition kinetics of the novel anticonvulsant HEPP (D,L-3-hydroxy-3-ethyl-3-phenylpropionamide) after subcutaneous administration in pregnant rats.
    Gómez-Martínez LE
    Int J Toxicol; 2007; 26(3):237-46. PubMed ID: 17564905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.